Weilai Tong

440 total citations
21 papers, 282 citations indexed

About

Weilai Tong is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Weilai Tong has authored 21 papers receiving a total of 282 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Cancer Research and 6 papers in Oncology. Recurrent topics in Weilai Tong's work include Cancer, Hypoxia, and Metabolism (3 papers), Spinal Cord Injury Research (3 papers) and Microtubule and mitosis dynamics (3 papers). Weilai Tong is often cited by papers focused on Cancer, Hypoxia, and Metabolism (3 papers), Spinal Cord Injury Research (3 papers) and Microtubule and mitosis dynamics (3 papers). Weilai Tong collaborates with scholars based in China and United States. Weilai Tong's co-authors include Jiaming Liu, Anan Li, Zhili Liu, Yang Zhou, Jiangbo Nie, Nanshan Zhong, Zhili Liu, Shijiang Wang, Zihao Liu and Jiaming Liu and has published in prestigious journals such as PLoS ONE, Scientific Reports and Cell Death and Disease.

In The Last Decade

Weilai Tong

18 papers receiving 281 citations

Peers

Weilai Tong
Weilai Tong
Citations per year, relative to Weilai Tong Weilai Tong (= 1×) peers Jiamin Zhou

Countries citing papers authored by Weilai Tong

Since Specialization
Citations

This map shows the geographic impact of Weilai Tong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weilai Tong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weilai Tong more than expected).

Fields of papers citing papers by Weilai Tong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weilai Tong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weilai Tong. The network helps show where Weilai Tong may publish in the future.

Co-authorship network of co-authors of Weilai Tong

This figure shows the co-authorship network connecting the top 25 collaborators of Weilai Tong. A scholar is included among the top collaborators of Weilai Tong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weilai Tong. Weilai Tong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xie, Xinsheng, et al.. (2025). Targeting the SYVN1-EGFR axis: a breakthrough strategy for TKI-resistant NSCLC. Cell Death and Disease. 16(1). 655–655.
2.
Tong, Weilai, Xinsheng Xie, Jiangbo Nie, et al.. (2025). SPICE1 promotes osteosarcoma growth by enhancing the deubiquitination of FASN mediated by USP10. Journal of Translational Medicine. 23(1). 220–220.
3.
Li, Anan, Shijiang Wang, Jiangbo Nie, et al.. (2024). USP3 promotes osteosarcoma progression via deubiquitinating EPHA2 and activating the PI3K/AKT signaling pathway. Cell Death and Disease. 15(3). 235–235. 9 indexed citations
4.
Tong, Weilai, et al.. (2024). KRT80 Promotes Lung Adenocarcinoma Progression and Serves as a Substrate for VCP. Journal of Cancer. 15(8). 2229–2244. 3 indexed citations
5.
Tong, Weilai, et al.. (2024). AURKB targets DHX9 to promote hepatocellular carcinoma progression via PI3K/AKT/mTOR pathway. Molecular Carcinogenesis. 63(9). 1814–1826. 10 indexed citations
6.
Wang, Shijiang, Jiangbo Nie, Anan Li, et al.. (2024). VCP enhances autophagy-related osteosarcoma progression by recruiting USP2 to inhibit ubiquitination and degradation of FASN. Cell Death and Disease. 15(11). 788–788. 6 indexed citations
7.
Liu, Zihao, Anan Li, Weilai Tong, et al.. (2023). Alpinetin inhibits neuroinflammation and neuronal apoptosis via targeting the JAK2/STAT3 signaling pathway in spinal cord injury. CNS Neuroscience & Therapeutics. 29(4). 1094–1108. 62 indexed citations
8.
Tong, Weilai, Shijiang Wang, Cheng He, et al.. (2023). CircREOS suppresses lipid synthesis and osteosarcoma progression through inhibiting HuR-mediated MYC activation. Journal of Cancer. 14(6). 916–926. 8 indexed citations
9.
Wang, Shijiang, Jiangbo Nie, Yang Liu, et al.. (2023). YY1 is regulated by ALKBH5-mediated m6A modification and promotes autophagy and cancer progression through targeting ATG4B. Aging. 15(18). 9590–9613. 11 indexed citations
10.
Zhang, Yu, et al.. (2022). Effect of screw tunnels on proximal femur strength after screw removal: A finite element analysis. Orthopaedics & Traumatology Surgery & Research. 108(8). 103408–103408. 4 indexed citations
11.
Li, Anan, Yu Zhang, Weilai Tong, et al.. (2022). Identification of a Novel Pyroptosis-Related Gene Signature Indicative of Disease Prognosis and Treatment Response in Skin Cutaneous Melanoma. International Journal of General Medicine. Volume 15. 6145–6163. 7 indexed citations
12.
Liu, Wencai, Shi‐Nan Wu, Weilai Tong, et al.. (2022). Using Machine Learning Methods to Predict Bone Metastases in Breast Infiltrating Ductal Carcinoma Patients. Frontiers in Public Health. 10. 922510–922510. 16 indexed citations
13.
Zhang, Yu, Anan Li, Shining Xiao, et al.. (2022). A Bibliometric Analysis of Publications on Spinal Cord Injury Treatment With Glucocorticoids Using VOSviewer. Frontiers in Public Health. 10. 907372–907372. 9 indexed citations
14.
Xiao, Shining, Nanshan Zhong, Anan Li, et al.. (2022). Aucubin promoted neuron functional recovery by suppressing inflammation and neuronal apoptosis in a spinal cord injury model. International Immunopharmacology. 111. 109163–109163. 20 indexed citations
15.
Zeng, Xianjun, Yu Zhang, Weilai Tong, et al.. (2022). Influence of ABO blood group on susceptibility to different pathological types of lung cancer: a retrospective study. World Journal of Surgical Oncology. 20(1). 379–379.
16.
Liu, Jiaming, et al.. (2020). Aurora-B knockdown inhibits osteosarcoma metastasis by inducing autophagy via the mTOR/ULK1 pathway. Cancer Cell International. 20(1). 575–575. 21 indexed citations
17.
Ye, Pei, Hui Sun, Jun Lin, et al.. (2018). Up-regulated MiR-27-3p promotes the G1-S phase transition by targeting inhibitor of growth family member 5 in osteosarcoma. Biomedicine & Pharmacotherapy. 101. 219–227. 19 indexed citations
18.
Zhou, Yang, et al.. (2017). Neuron-specific enolase, histopathological types, and age as risk factors for bone metastases in lung cancer. Tumor Biology. 39(7). 2901591826–2901591826. 9 indexed citations
19.
Liu, Jiaming, Weilai Tong, Yang Zhou, et al.. (2017). The incidences and risk factors related to early dysphagia after anterior cervical spine surgery: A prospective study. PLoS ONE. 12(3). e0173364–e0173364. 25 indexed citations
20.
Zhou, Yang, et al.. (2017). The risk factors of bone metastases in patients with lung cancer. Scientific Reports. 7(1). 8970–8970. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026